港股异动｜海吉亚医疗盘初涨超6% 计划回购不超3亿股股份

Group 1 - The core viewpoint of the article is that Haijia Medical (6078.HK) believes its current share price does not reflect its intrinsic value or actual business prospects, prompting the company to initiate a share buyback program [1] - Haijia Medical's share price initially rose over 6%, currently trading at 12 HKD, with a total market capitalization of 7.45 billion HKD [1] - The company plans to utilize its buyback authorization to repurchase shares in the open market for a total price of no less than 300 million RMB [1] Group 2 - The company aims to continuously optimize shareholder returns based on market conditions, focusing on efficient capital allocation through buybacks, dividends, and merger expansions [1]